Mayne will regain favour soon enough. a few product approvals like today will help fund managers see through whether eanrings are 1-2% above or below forecast and will focus on the eanrings growth potential of this company
A healthcare stock with a PE of under 11, low debt, diversifed with significant earnings grow, is a steal
worth at least 1.50 -170 imo
Mayne will regain favour soon enough. a few product approvals...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.81 |
Change
0.140(3.00%) |
Mkt cap ! $409.2M | |||
| Open | High | Low | Value | Volume |
| $4.80 | $4.85 | $4.73 | $571.8K | 119.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 556 | $4.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.81 | 1694 | 1 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| MYX (ASX) Chart |